AngioDynamics
Latham
About AngioDynamics
AngioDynamics, (AngioDynamics) is a provider of medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease (PVD) and local oncology therapy options for treating cancer, including radiofrequency ablation (RFA) systems, embolization products for treating benign and malignant tumors and surgical resection systems, including NanoKnife Ablation Systems. It designs, develops, manufactures and markets a line of therapeutic and diagnostic devices that enable interventional physicians (interventional radiologists, vascular surgeons, surgical oncologists and others) to treat PVD, tumors, and other non-coronary diseases. The Company’s segments include Vascular segment, which is responsible for products targeting the venous intervention, dialysis access, thrombus management and peripheral disease markets, and Oncology /Surgery segment, is responsible for radio frequency (RF) Ablation, embolization, Habib and NanoKnife product lines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Ticker: nasdaq:ANGO
- Website: angiodynamics.com
- Phone: 5187424465
Industries & Categories
Biotechnology, Hardware, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/angiodynamics-2238248 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.